TERT-BUTYL (5-BROMO-4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)CARBAMATE

Catalog No. :
ACNUVE695
CAS No. :
1542268-23-4
Molecular Formula :
C11H12BrF3N2O2
Molecular Weight :
341.13

IUPAC Name:tert-butyl (5-bromo-4-(trifluoromethyl)pyridin-2-yl)carbamate

TERT-BUTYL (5-BROMO-4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)CARBAMATE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$217.00Login to see priceInquiryInquiry
1g95%$542.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTERT-BUTYL (5-BROMO-4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)CARBAMATE
IUPAC Nametert-butyl (5-bromo-4-(trifluoromethyl)pyridin-2-yl)carbamate
Molecular FormulaC11H12BrF3N2O2
Molecular Weight341.13
SMILESFC(F)(F)C1=CC(NC(OC(C)(C)C)=O)=NC=C1Br
InChI KeyIUCWBTFNXRCLTM-UHFFFAOYSA-N
SynonymTert-butyl (5-bromo-4-(trifluoromethyl)pyridin-2-YL)carbamate;Carbamic acid, N-[5-bromo-4-(trifluoromethyl)-2-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1542268-23-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNUVE695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPYHD916 route compound structure diagram
    ACPYHD916944401-56-3 In Stock
  4. Then
  5. ACNUVE695 route product structure diagram
    ACNUVE6951542268-23-4
Inquiry

2. ACNUVE695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5 In Stock
  2. Plus
  3. ACPYJX763 route compound structure diagram
    ACPYJX763823221-93-8 In Stock
  4. Then
  5. ACNUVE695 route product structure diagram
    ACNUVE6951542268-23-4
Inquiry

Comments (0)